Rachel T. Klein

892 total citations
15 papers, 600 citations indexed

About

Rachel T. Klein is a scholar working on Pathology and Forensic Medicine, Genetics and Cancer Research. According to data from OpenAlex, Rachel T. Klein has authored 15 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 9 papers in Genetics and 8 papers in Cancer Research. Recurrent topics in Rachel T. Klein's work include Cancer Genomics and Diagnostics (8 papers), Genetic factors in colorectal cancer (8 papers) and BRCA gene mutations in cancer (7 papers). Rachel T. Klein is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Genetic factors in colorectal cancer (8 papers) and BRCA gene mutations in cancer (7 papers). Rachel T. Klein collaborates with scholars based in United States, France and Germany. Rachel T. Klein's co-authors include Kathleen S. Hruska, Lisa R. Susswein, Megan L. Marshall, Maegan E. Roberts, Zhixiong Xu, Patricia D. Murphy, Wendy K. Chung, Daniel Pineda‐Alvarez, Benjamin D. Solomon and Kristen J. Vogel Postula and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and Annals of Surgical Oncology.

In The Last Decade

Rachel T. Klein

14 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel T. Klein United States 10 354 299 205 204 140 15 600
Steven Keiles United States 8 281 0.8× 120 0.4× 131 0.6× 101 0.5× 118 0.8× 13 558
Kun Y. Lee United States 8 212 0.6× 127 0.4× 290 1.4× 200 1.0× 342 2.4× 11 557
Rohan Gnanaolivu United States 6 165 0.5× 108 0.4× 247 1.2× 155 0.8× 302 2.2× 9 467
Inbal Kedar Israel 15 155 0.4× 108 0.4× 67 0.3× 120 0.6× 76 0.5× 42 383
Douglas F. Easton United Kingdom 6 195 0.6× 96 0.3× 78 0.4× 265 1.3× 155 1.1× 8 510
Yvonne Engwall Sweden 7 161 0.5× 271 0.9× 95 0.5× 165 0.8× 160 1.1× 9 508
Jennifer L. Geurts United States 9 290 0.8× 41 0.1× 102 0.5× 245 1.2× 136 1.0× 27 505
Thomas A. Lallas United States 11 151 0.4× 93 0.3× 85 0.4× 171 0.8× 133 0.9× 17 435
Gianluca Tedaldi Italy 10 121 0.3× 99 0.3× 152 0.7× 195 1.0× 147 1.1× 28 409
Astrid Bechtold Germany 5 197 0.6× 46 0.2× 142 0.7× 93 0.5× 76 0.5× 5 308

Countries citing papers authored by Rachel T. Klein

Since Specialization
Citations

This map shows the geographic impact of Rachel T. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel T. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel T. Klein more than expected).

Fields of papers citing papers by Rachel T. Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel T. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel T. Klein. The network helps show where Rachel T. Klein may publish in the future.

Co-authorship network of co-authors of Rachel T. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel T. Klein. A scholar is included among the top collaborators of Rachel T. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel T. Klein. Rachel T. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Marshall, Megan L., Maegan E. Roberts, Lisa R. Susswein, et al.. (2020). Differences in cancer prevalence among CHEK2 carriers identified via multi-gene panel testing. Cancer Genetics. 246-247. 12–17. 25 indexed citations
2.
Roberts, Maegan E., Lisa R. Susswein, Natalie J. Carter, et al.. (2020). Ancestry‐specific hereditary cancer panel yields: Moving toward more personalized risk assessment. Journal of Genetic Counseling. 29(4). 598–606. 14 indexed citations
3.
Mester, Jessica L., Sarah A. Jackson, Kristen J. Vogel Postula, et al.. (2019). Apparently Heterozygous TP53 Pathogenic Variants May Be Blood Limited in Patients Undergoing Hereditary Cancer Panel Testing. Journal of Molecular Diagnostics. 22(3). 396–404. 18 indexed citations
4.
Arvai, Kevin J., Maegan E. Roberts, Rebecca I. Torene, et al.. (2019). Age-adjusted association of homologous recombination genes with ovarian cancer using clinical exomes as controls. Hereditary Cancer in Clinical Practice. 17(1). 19–19. 9 indexed citations
5.
Thompson, Amanda, Megan L. Marshall, Maegan E. Roberts, et al.. (2019). Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis. Familial Cancer. 18(2). 203–209. 29 indexed citations
6.
Roberts, Maegan E., John Michael O. Rañola, Megan L. Marshall, et al.. (2019). Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers. JAMA Oncology. 5(9). 1325–1325. 99 indexed citations
7.
Roberts, Maegan E., Sarah A. Jackson, Lisa R. Susswein, et al.. (2018). MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer. Genetics in Medicine. 20(10). 1167–1174. 105 indexed citations
8.
Marshall, Megan L., Maegan E. Roberts, Lisa R. Susswein, et al.. (2018). High prevalence of pathogenic variants in individuals with colorectal cancer ≤ age 35.. Journal of Clinical Oncology. 36(4_suppl). 576–576. 2 indexed citations
9.
Susswein, Lisa R., Megan L. Marshall, Maegan E. Roberts, et al.. (2018). Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis. Annals of Surgical Oncology. 25(12). 3556–3562. 6 indexed citations
10.
Jackson, Sarah A., Maegan E. Roberts, Jessica L. Mester, et al.. (2018). Mosaic TP53 pathogenic variants on multi-gene hereditary cancer panel testing: Clinical characteristics and follow-up testing.. Journal of Clinical Oncology. 36(15_suppl). 1580–1580. 1 indexed citations
11.
Carter, Natalie J., Megan L. Marshall, Lisa R. Susswein, et al.. (2018). Germline pathogenic variants identified in women with ovarian tumors. Gynecologic Oncology. 151(3). 481–488. 40 indexed citations
12.
Jackson, Sarah A., Jessica L. Mester, Lisa R. Susswein, et al.. (2017). Multigene hereditary cancer testing in sarcoma patients.. Journal of Clinical Oncology. 35(15_suppl). 1518–1518.
13.
Meck, Jeanne, Ludmila Matyakhina, Ayala Aviram, et al.. (2015). Noninvasive prenatal screening for aneuploidy: positive predictive values based on cytogenetic findings. American Journal of Obstetrics and Gynecology. 213(2). 214.e1–214.e5. 41 indexed citations
14.
Susswein, Lisa R., Megan L. Marshall, Rachel Nusbaum, et al.. (2015). Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genetics in Medicine. 18(8). 823–832. 199 indexed citations
15.
Klein, Rachel T., et al.. (2007). Further delineation of interstitial chromosome 6 deletion syndrome and review of the literature. Clinical Dysmorphology. 16(3). 135–140. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026